Chromosomal Abnormalities in Embryonic and Somatic Stem Cells

Cytogenet Genome Res. 2015;147(1):1-9. doi: 10.1159/000441645. Epub 2015 Nov 20.

Abstract

The potential use of stem cells (SCs) for tissue engineering, regenerative medicine, disease modeling, toxicological studies, drug delivery, and as in vitro model for the study of basic developmental processes implies large-scale in vitro culture. Here, after a brief description of the main techniques used for karyotype analysis, we will give a detailed overview of the chromosome abnormalities described in pluripotent (embryonic and induced pluripotent SCs) and somatic SCs, and the possible causes of their origin during culture.

Publication types

  • Review

MeSH terms

  • Animals
  • Cell Line
  • Chromosome Aberrations*
  • Chromosome Banding
  • Comparative Genomic Hybridization
  • Embryonic Stem Cells / metabolism
  • Embryonic Stem Cells / pathology*
  • Endothelial Progenitor Cells / metabolism
  • Endothelial Progenitor Cells / pathology
  • Hematopoietic Stem Cells / metabolism
  • Hematopoietic Stem Cells / pathology
  • Humans
  • In Situ Hybridization, Fluorescence
  • Induced Pluripotent Stem Cells / metabolism
  • Induced Pluripotent Stem Cells / pathology*
  • Karyotyping
  • Mesenchymal Stem Cells / metabolism
  • Mesenchymal Stem Cells / pathology
  • Mice
  • Neural Stem Cells / metabolism
  • Neural Stem Cells / pathology